Still Missing, The Prostate Cancer Community
Here it is June 11 and my frustration with the Prostate Cancer Community continues to climb. On May 31, I wrote that the FDA had compromised over the issue of the approval of Provenge. At that time, it was announced that the FDA would be willing to use the interim results of Dendreon’s current, on [...]
